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Abstract
Purpose To report a case of peripapillary
choroidal neovascularization (CNV)
complicating serpiginous choroiditis that was
treated by a single indocyanine green (ICG)-
mediated photothrombosis session combined
to intravitreous triamcinolone acetonide (TA)
injection.
Methods Interventional case report. A
48-year-old patient with peripapillary CNV
was submitted to a laser-dye-mediated
technique that uses ICG and low-intensity
810-nm light for continuous laser application;
TA was then injected into the vitreous cavity
1 hour later, and prospective evaluation with
fluorescein and ICG angiography as well
as optical coherence tomography (OCT)
was performed.
Results At 2 weeks after treatment, best-
corrected visual acuity improved from 20/200
to 20/50, with further improvement to 20/201
in the subsequent 10 weeks. Absence of
fluorescein leakage from the CNV and OCT
evidence of resolved retinal oedema was
observed at that time. Clinical stabilization
was maintained up to 1 year of follow-up.
There was no significant complication related
to the procedure.
Conclusion Combined ICG-mediated
photothrombosis and intravitreous TA
induced rapid and significant visual
acuity recovery in this particular case of
peripapillary CNV complicating serpiginous
choroiditis. Accordingly, angiographic and
OCT findings demonstrated neovascular
lesion regression and restoration of the
macular architecture.
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Serpiginous choroidopathy is a chronic
recurring disorder, usually bilateral and
asymmetrical, which primarily affects the
choriocapillaris and retinal pigment epithelium
with disruption of the overlying neurosensory
retina. The aetiology is uncertain, although an
inflammatory cause has been suggested.1
Clinical course of this progressive disease
varies, particularly with regard to the central
vision prognosis. Although slow visual
recovery is likely to occur,2 profound visual loss
happens if foveal or parafoveal areas are
involved or secondary choroidal
neovascularization (CNV) development is
noticed.3 This communication reports the
treatment and follow-up of one patient with
serpiginous choroidopathy, complicated with a
peripapillary CNV, who was treated with
combined indocyanine green (ICG)-mediated
photothrombosis and intravitreous
triamcinolone acetonide (TA) injection.
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Case report
A 48-year-old white man with no previous systemic
disease complained of decreased visual acuity in the right
eye 1 week prior to presentation. His best-corrected visual
acuity (BCVA) was 20/80 in the right eye and 20/20 in the
left eye. Ophthalmologic examination revealed
asymmetrical scarring with clumping and loss of retinal
pigment epithelium (RPE), and destruction of the
choroidal vasculature in the peripapillary region of both
eyes. Some inflammatory cells were observed in the
posterior vitreous and one foci of active choroiditis was
suspected in the right eye. No other signs such as
peripheral retinal lesions, optic disc involvement,
polypoidal lesions, and angioid streaks were encountered.
The diagnosis at that time was serpiginous choroiditis
based on these findings and in the results of serologic tests
and haematological evaluation. Oral corticosteroids were
prescribed and by 2 weeks, the BCVA had further
decreased to 20/125þ 2 caused by a subretinal
haemorrhage involving the macular region and increase in
retinal oedema. Fluorescein and ICG angiography
revealed a CNV emanating from the leading edge of the
peripapillary scar (Figure 1a-d). Since BCVA dropped to
20/200 even in the presence of oral medication because of
CNV progression and enlarged subretinal haemorrhage
in the following 2 weeks (Figure 1e), ICG-mediated
photothrombosis was proposed to the patient. The
decision for the combined procedure with intravitreous
TA injection was based on the presence of residual
vitreous cells at the last examination prior to treatment.
ICG-mediated photothrombosis is a modality of laser-
dye treatment that uses large-spot, low-intensity 810-nm
light to apply laser energy continuously to an area where
ICG has been highly concentrated,4 used recently in the
management of CNV associated with age-related
macular degeneration.5 The study protocol was
approved by the local institutional review board and a
written informed consent was obtained before treatment.
For the procedure, a loading dose of 2.0 ml of a highly
concentrated solution of ICG (25 mg/ml (approximately
1 mg/kg body weight)) was administered as an i.v. bolus,
followed immediately by a 5.0-ml saline flush. At 20 min
after the loading dose, a second i.v. injection of 50 mg of
ICG in 2 ml of solution was administered, followed by a
5.0-ml saline flush. At 90 s after the second flush infusion,
Figure 1 (a, b) Red-free fundus photography demonstrating typical aspect of peripapillary scarring with fingerlike extensions
oriented superiorly and inferiorly in the right eye. Subretinal haemorrhage and increased retinal oedema within the papillomacular
bundle region was seen 2 weeks after presentation. A suspected focus of active choroiditis was seen along the superotemporal vessels
(arrowhead). Peripapillary chorioretinal scar with superonasal fingerlike extension and pigment clumping was also seen in the left eye.
(c) Late-phase ICG angiography at that time demonstrated hypofluorescent areas consistent with loss of choriocapillaris and RPE
commonly observed in healed areas of serpiginous choroiditis. An active CNV adjacent to the leading edge of the old scar at
the temporal aspect of the optic disc (arrows) was seen. Subretinal haemorrhage blocks fluorescence in the macular area. Mild
hyperfluorescence at the suspected region of choroiditis was also seen (arrowhead). (d) Multiple hypofluorescent spots throughout the
macula and the peripapillar region of both eyes were demonstrated by late-phase ICG angiography. Note that angiographic alterations
were confined to the posterior pole. (e) At 2 weeks after CNV detection, further increase in the area of the subretinal haemorrhage and
exudation was observed caused by the extension of the CNV inferiorly. Dotted lines represent the delineation of the suspected
neovascular lesion. (f) Late-phase ICG angiography taken after laser treatment and 5 min before intravitreal triamcinolone injection.
Two spots (dotted lines) positioned first over the inferior CNV part, and secondly over the superior part were used for laser
applications. (g, h) Early-phase fluorescein and ICG angiography taken 12 weeks after combined treatment showed an absence of
fluorescein leakage from neovascular lesion and resolution of subretinal haemorrhage. A well-defined irregular hypofluorescent region
corresponding to the entire neovascular lesion seen in fluorescein angiograms before treatment was evidenced on ICG angiography.
Note that the deeper choroidal vasculature within the area correspondent to the former CNV was preserved and no angiographic
alteration was identified in the normal tissues involved in the treatment spot area.
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a diode laser at 810 nm (Trimode-L, OPTO, Sa˜o Carlos,
Brazil) with a slit-lamp delivery system was used at an
intensity of 5.6 W/cm2 over 90 s to deliver light to the
fundus utilizing a 2.25 mm spot. The spot was positioned
initially at the inferior part of the CNV and secondly at
the superior CNV part. At 20 min after the conclusion of
the first laser applications, light dose at the same
parameters was applied a second time in the exactly
same positions at the fundus (Figure 1f). An intravitreous
injection of 0.1 ml containing 4 mg of TA was then
performed 60 min after the second (and last) laser
applications (Figure 2b). By 2 weeks, the BCVA improved
to 20/50 and optical coherence tomography (OCT)
demonstrated a reduction in retinal elevation and
subretinal fluid (Figure 2a, c). At 12 weeks, vision
improved to 20/20-1, and OCT revealed a complete
restoration of the macular architecture and a quiescent
neovascular lesion in the peripapillary region (Figures
1g, h, and 2d). At 1 year after treatment, BCVA remained
stable and no fluid was detected on OCT evaluation
(Figure 2e, f). No significant alteration in intraocular
pressure was seen during follow-up and there were no
complications related to the procedure.
Comment
Management of peripapillary CNV remains an unsolved
matter among retinal specialists. The particular CNV
shape and the proximity of the optic disc may lead to
difficulties in positioning the circular laser spot for light
applications. In the case we described, light application
had to be positioned in two separated spots to achieve
complete CNV treatment. Additionally, we must
consider that depending on the iatrogenic laser-induced
damage to the inner retinal layers, irreversible visual
field scotoma might occur. The use of an 810 nm laser as
well as lower intensity levels for the treatment (at least
100 times lower than that commonly used for fundus
photocoagulation) in association with ICG was sufficient
to avoid such an effect. Similar association has also
demonstrated promising results for the management of
haemangiomas6 and metastasis7 involving the choroid.
Taking into consideration that some benefit was
achieved after intravitreous TA in exudative age-related
macular degeneration8 and that inflammatory factors
may also be involved in the pathogenesis of serpiginous
choroiditis,1 we believe that association of intravitreal TA
to the laser-dye procedure in our patient might have
played an important role in the final clinical outcome.
In conclusion, the location of the CNV in the case
reported was within the papillomacular bundle, allowing
the possibility of a severe visual acuity to occur if
conventional laser photocoagulation was performed.
Given the visual improvement in this patient, combined
ICG-mediated photothrombosis and intravitreal TA may
be an effective tool in the management of CNV in
patients with serpiginous choroiditis. Whether or not the
sole use of intravitreal TA or ICG-mediated
photothrombosis responds in a similar manner to the
combined technique for CNV treatment in serpiginous
choroiditis requires further investigation.
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